FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Xortx to Pursue Accelerated Approval for Xorlo

Xortx says a meeting with FDA staff provided the information needed to initiate a Phase 3 study of its Xorlo to treat autosomal dominant polycystic ki...

Medical Devices

Device Regulatory Science Tool Catalog Update

FDA adds three new tools to the Catalog of Regulatory Science Tools to Help Assess New Medical Devices and updates listings for five existing tools.

latest-news-card-1
FDA General

Califf Recommends FDA Reforms for Pandemic Bill

FDA commissioner Robert Califf tells a Senate HELP hearing that FDA inspection, diagnostic devices, and supply chain transparency reforms are needed.

latest-news-card-1
Human Drugs

2-Day Workshop on Rare Disease Endpoints

FDA and the Duke-Margolis Center for Health Policy announce a 6/7-8 public workshop on the agencys Rare Disease Endpoint Advancement Pilot Program.

latest-news-card-1
Federal Register

Panel to Mull Strain Selection for Covid Vaccine

Federal Register notice: FDA announces a 6/15 advisory committee to select strain(s) to be included in the Covid19 vaccines for the 20232024 season.

latest-news-card-1
Federal Register

Comments Sought on Nitrosamine Impurities

Federal Register notice: FDA creates a docket to receive public comments on the identification, assessment, and control of N-nitrosamine drug substanc...

latest-news-card-1
Human Drugs

FDA Novo Nordisk Concizumab Complete Response Letter

FDA issues a complete response letter for Novo Nordisks concizumab, asking for additional dosing and manufacturing information.

latest-news-card-1
Medical Devices

FDA Warning on Contaminated Covid Tests

FDA issues a warning on SD Biosensors Pilot Covid-19 At-Home Tests due to bacterial contamination concerns with its liquid solution.

latest-news-card-1
Human Drugs

Members of Congress Seek Mifepristone Reversal

More than 250 Democrat members of the House and Senate petition the 5th Circuit Court of Appeals to overturn a Texas federal court decision banning th...

latest-news-card-1
Human Drugs

Rentschler Biopharma Germany Site 483

FDA leaves a five-item Form FDA-483 after a 2/27-3/7 inspection of Rentschler Biopharmas manufacturing facility in Baden-Wurttemberg, Germany.